| Methods |
Quasi‐randomised trial (4‐armed trial, only 2 arms used for the current review)
Open
2000‐2002 |
| Participants |
Number: 44 patients
Age: mean 52, SD 13.6 |
| Interventions |
piperacillin‐tazobactam 4.5grX3
versus
cefepime 2grX2 |
| Outcomes |
Infection‐related mortality
Clinical failure
Drug modifications |
| Notes |
Israel |
| Risk of bias |
| Bias |
Authors' judgement |
Support for judgement |
| Adequate sequence generation? |
High risk |
According to patient's room |
| Allocation concealment? |
High risk |
According to patient's room |
| Blinding?
All outcomes |
High risk |
Blinding not used |
| Incomplete outcome data addressed?
All‐cause mortality |
Low risk |
|
| Incomplete outcome data addressed?
Treatment failure |
Low risk |
|
| Free of other bias? |
Low risk |
|
